We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Healthy prognosis

15 July 2014 By Antony Currie, Daniel Indiviglio

The lender got through two quarters in a row without socking away huge amounts to cover legal costs. That’ll be a relief for the CEO as he starts cancer treatment. What’s more, core earnings improved for the first time in a year. Returns are still mediocre, but it’s a start.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)